^
    BIOMARKER:

    CDKN2A deletion

    i
    Other names: CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A




    Show legend

    Include preclinical:
    Melanoma
    Acute Lymphocytic Leukemia
    Hepatocellular Cancer
    B Acute Lymphoblastic Leukemia
    Gastric Adenocarcinoma
    Diffuse Large B Cell Lymphoma
    Prolymphocytic Leukemia
    Estrogen Receptor Positive Breast Cancer
    Ewing Sarcoma
    Renal Cell Carcinoma
    Pancreatic Ductal Adenocarcinoma
    HER2 Positive Breast Cancer
    Mantle Cell Lymphoma
    Gallbladder Cancer
    Glioma
    Pancreatic Cancer
    blinatumomab
    palbociclib
    palbociclib + JQ-1
    ibrutinib
    vincristine + lomustine + procarbazine hydrochloride
    palbociclib + VRx-510
    ribociclib + VRx-510
    ASP7487
    temsirolimus
    abemaciclib + tucatinib
    alemtuzumab
    Immunotherapy
    T-lymphocyte cell therapy
    BET inhibitor + CDK inhibitor